Vimta Labs Ltd logo

Vimta Labs Ltd

VIMTALABS NSE

Key Fundamentals

MicrocapHealthcare TechnologyHealthcare
Market Cap
₹2,859 Cr
Volatility
Moderate
P/E Ratio
36.04
EBITDA
₹90.80 Cr
Return on Equity
12.83%
Debt to Equity
0.01
Book Value
₹102.24
EPS
₹18.53
52W High
₹902.65
52W Low
₹376.05

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vimta Labs Ltd insights

46 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 30.0% CAGR over last 5 years

Growth Rate

Revenue Growth
0.22% ↘
Net Income Growth
-14.94% ↘
Cash Flow Change
-30.76% ↘
ROE
-24.97% ↘
ROCE
-26.21% ↘
EBITDA Margin (Avg.)
-7.88% ↘

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
82
64
73
73
75
85
90
94
98
102
99
109
109
Expenses
58
48
50
47
49
55
57
61
64
68
64
70
72
Operating Profit
24
17
23
26
26
30
33
33
34
34
34
39
37
OPM %
29%
26%
31%
36%
35%
35%
37%
35%
35%
34%
35%
36%
34%
Other Income
1
0
-1
-1
-1
-1
5
2
2
3
0
3
4
Interest
0
1
1
1
0
0
1
0
0
0
0
0
0
Depreciation
8
9
8
8
8
8
10
9
10
10
11
13
13
PBT
16
8
13
16
17
20
28
25
25
26
23
29
28
Tax %
25%
25%
25%
24%
26%
24%
23%
27%
25%
24%
25%
27%
26%
Net Profit
12
6
9
12
12
15
22
18
19
20
18
21
21
EPS in Rs
2.63
1.34
2.14
2.79
2.77
3.44
4.84
4.12
4.24
4.47
3.94
4.73
4.71
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
116
138
154
183
213
181
209
276
315
289
344
407
419
Expenses
99
119
127
138
155
151
156
196
222
195
222
266
274
Operating Profit
17
19
27
45
58
30
53
80
94
94
122
142
145
OPM %
15%
14%
18%
25%
27%
17%
25%
29%
30%
33%
35%
35%
35%
Other Income
1
1
1
1
2
3
1
0
3
-4
5
7
9
Interest
1
1
2
5
5
4
2
2
3
2
2
1
1
Depreciation
11
10
10
16
20
21
23
23
31
33
35
44
46
PBT
7
8
17
26
35
8
28
55
64
55
90
104
107
Tax %
24%
23%
36%
36%
28%
17%
25%
26%
26%
25%
25%
25%
—
Net Profit
5
6
11
16
25
7
21
41
47
41
67
78
80
EPS in Rs
1.14
1.45
2.4
3.72
5.73
1.57
4.81
9.29
10.68
9.26
15.13
17.35
17.85
Div. Payout %
44%
34%
0%
27%
17%
0%
21%
11%
9%
11%
7%
12%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4
4
4
4
4
4
4
4
4
4
4
9
Reserves
118
122
132
148
167
169
190
229
276
310
374
448
Borrowings
4
26
44
40
26
32
30
19
15
19
9
3
Other Liabilities
21
23
42
40
40
39
49
54
65
61
79
102
Total Liabilities
146
176
222
232
237
245
273
306
360
394
467
562
Fixed Assets
88
88
88
140
135
131
128
162
168
166
230
305
CWIP
0
6
53
0
4
2
17
0
12
59
38
18
Investments
0
0
0
0
0
6
6
6
6
0
0
2
Other Assets
58
82
80
92
99
105
122
138
174
170
198
237
Total Assets
146
176
222
232
237
245
273
306
360
394
467
562
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
15
-1
24
33
39
24
37
59
87
61
94
147
Investing
-8
-16
-39
-24
-16
-20
-32
-38
-57
-76
-76
-130
Financing
-9
19
13
-8
-23
-1
-5
-16
-11
-2
-16
-10
Net Cash Flow
-1
2
-2
1
1
3
1
5
19
-17
2
7
Free Cash Flow
8
-17
-16
9
23
10
5
20
37
-14
17
47
CFO/OP
96
4
107
86
85
101
84
94
106
81
95
121
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
82
100
101
111
100
117
128
102
93
110
113
95
Inventory Days
158
213
183
209
199
191
140
154
195
260
210
203
Days Payable
66
77
184
148
115
114
139
108
124
87
88
79
Cash Conversion Cycle
174
236
100
172
184
194
128
147
164
283
235
219
Working Capital Days
109
99
22
62
78
64
89
87
78
98
96
83
ROCE %
6%
7%
11%
17%
21%
6%
14%
24%
24%
20%
25%
25%

Shareholding Pattern

As of Jun 2026
Promoters 35.67%
Others 34.52%
Public 25.03%
FIIs 4.42%
DIIs 0.37%
Total 100.01%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
37.46%
37.46%
37.46%
37.46%
37.46%
37.46%
37.46%
37.25%
37.24%
37.23%
37.01%
36.98%
36.92%
36.89%
36.89%
36.76%
36.70%
36.67%
35.99%
35.90%
35.85%
35.67%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
2.74%
0.00%
5.13%
5.16%
3.31%
3.81%
3.66%
3.49%
4.33%
4.59%
4.89%
4.42%
DIIs
0.00%
0.00%
1.29%
1.48%
1.48%
1.48%
1.48%
2.13%
2.14%
2.13%
1.50%
1.49%
1.50%
1.49%
0.00%
1.16%
1.43%
1.42%
0.87%
0.11%
0.14%
0.37%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
29.08%
29.45%
28.48%
27.35%
27.07%
26.99%
26.79%
25.06%
25.19%
24.60%
25.00%
25.15%
23.08%
23.13%
26.53%
25.09%
25.17%
24.02%
24.62%
25.12%
25.01%
25.03%
Others
33.46%
33.09%
32.77%
33.71%
34.00%
34.07%
34.27%
35.56%
35.43%
36.04%
33.75%
36.38%
33.37%
33.33%
33.27%
33.18%
33.03%
34.40%
34.18%
34.29%
34.11%
34.52%
No. of Shareholders
12,152
20,928
19,947
19,194
18,332
18,106
18,283
18,916
17,162
17,439
18,429
19,957
18,550
19,054
20,114
21,156
26,183
29,867
55,933
54,467
51,623
50,190

Documents

Frequently Asked Questions about Vimta Labs Ltd

What does Vimta Labs Ltd do?
Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider[1]
Where is Vimta Labs Ltd (VIMTALABS) listed?
Vimta Labs Ltd is listed on the Indian stock exchanges. It is listed on NSE: VIMTALABS and BSE: 524394. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Vimta Labs Ltd belong to?
Vimta Labs Ltd operates in the Healthcare sector within the Healthcare Technology industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Vimta Labs Ltd?
Vimta Labs Ltd has a market capitalisation of approximately ₹2859.06 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Vimta Labs Ltd?
The Price-to-Earnings (PE) ratio of Vimta Labs Ltd is 36.04. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Vimta Labs Ltd?
Over the past 52 weeks, Vimta Labs Ltd has traded between a low of ₹376.05 and a high of ₹902.65. This range helps investors understand the stock's price volatility and recent trading levels.
Does Vimta Labs Ltd pay dividends?
Yes, Vimta Labs Ltd has a dividend yield of 0.31%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Vimta Labs Ltd?
Vimta Labs Ltd has a Return on Equity (ROE) of 12.83%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Vimta Labs Ltd on Tapetide?
On Tapetide, you can view Vimta Labs Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider[1]

Website vimta.com
CEO Dr. Sivalinga Prasad Vasireddi
Employees 1,315
Listed 2005-12-15
Face Value ₹ 2
Issued Size 4,46,35,189

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List